Gastrointestinal Infection Testing Market
Global Market Study on Gastrointestinal Infection Testing: Surge in Use of Sophisticated Infection Detection Panels in Bacterial GI Testing Anticipated to Push Growth
Leading Manufacturers Contribute 61.2% to the Market Revenue
The gastrointestinal infection testing market is largely dominated by a few major players who are competing based on product advancements and pricing in the gastrointestinal infection testing market. Introduction of novel products by manufacturers and growing patient pool are the key factors expected to boost the growth of the gastrointestinal infection testing market during the forecast period.
Companies, such as Hoffmann-La Roche Ltd., bioMérieux SA, and Thermo Fisher Scientific Inc., contribute 61.2% of the total revenue share in the global gastrointestinal infection testing market.
Find Out More about the Report Coverage
- Becton, Dickinson and Company (BD)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Luminex Corporation
- Hoffmann-La Roche Ltd.
- bioMérieux SA
- Quidel Corporation
- Illumina, Inc.
- Seegene Inc
- Genetic Signatures
Rising Burden of Diarrheal Disease and Increasing Patient Pool to Push Market Growth
Lack of proper medical facilities, improper sanitation facilities and unhygienic behavior of people, especially in emerging economies, such as India, China, Brazil, South Africa and Mexico, are some of the important factors leading to increasing cases of diarrheal diseases. The expanding patient pool is expected to increase the demand for better gastrointestinal infection testing options.
According to WHO, In 2016, the mortality rate due to diarrhea was about 3 times more in adults aged 70 years and above than in younger children aged 5 years and above. Additionally, different geographies represent a big opportunity for medical device manufacturers. This, in turn, has been acting as a driving factor for the growth of the gastrointestinal infection testing market.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Introduction of Novel Testing Devices to Boost Growth
Advancements in gastrointestinal infection testing have led to the development of new gastrointestinal infection testing products, which can rapidly detect infectious pathogens, such as bacteria, virus and parasites. This has led to the development of syndromic panels to detect syndromic infection.
A bioMérieux company has developed a syndromic panel for several infectious diseases. Luminex has two gastrointestinal infection testing panels. In November 2016, Bio-Rad received commercialization rights in certain unidentified areas to detect microbial imbalances in partnership with Genetic Analysis. Such technological advancements are boosting the growth of gastrointestinal infection testing market.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Companies Are Entering into Mergers and Expansions to Expand in the Market
Mergers and acquisitions are the prime business strategies being adopted by companies to expand their product portfolio and to enter into new markets. In the U.S., a decrease in life science funding has encouraged companies to actively migrate their technologies for clinical applications.
Several companies have made investments into clinical trials and are entering into expansion activities to enter into new market segments. Similarly, many companies are also merging or acquiring other companies that already have presence in the IVD industry. Such merger and expansion activities are pushing the growth of the gastrointestinal infection testing market.
Explore Persistence Market Research’s expertise in promulgation of the business !
Competitive Landscape of the Global Gastrointestinal Infection Testing Market
The competition section of the gastrointestinal infection testing market provides detailed information about key players competing in the gastrointestinal infection testing market based on their market shares, different market strategies, product offerings, marketing approach and company dashboard.
Some of the key players featured in this gastrointestinal infection testing market report include Becton, Dickinson, and Company (BD), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Luminex Corporation, Hoffmann-La Roche Ltd., bioMérieux SA, Quidel Corporation, Illumina, Inc., Seegene Inc and Genetic Signatures.
Gastrointestinal (GI) infections are mainly caused by a huge variety of bacteria, virus or parasites. GI infections cause irritation in the gastrointestinal tract, including both the stomach and small intestine. The symptoms include diarrhea, abdominal pain and vomiting.
About the Report
The company conducted a research study on the gastrointestinal infection testing market for the forecast period 2018 to 2026. This report provides thorough assessment of opportunities in the gastrointestinal infection testing market along with an understanding of the populations at risk, population groups opting for gastrointestinal infection testing, disease incidences, awareness level about gastrointestinal infection testing and competition in the gastrointestinal infection testing market.
The report provides thorough information regarding macroeconomic factors impelling the dynamics in the gastrointestinal infection testing market.
The report offers a wide-ranging taxonomy of the gastrointestinal infection testing market. The gastrointestinal infection testing market has been segmented on the basis of disease strains, product type, end-user and region. The gastrointestinal infection testing market has been segmented based on disease strains into bacterial strains, viral strains and parasitic strains. T
he gastrointestinal infection testing market has been segmented by product type into reagent kits, sequencing kits and equipment. By end user, the gastrointestinal infection testing market is segmented into hospitals, clinics/medical centers, research Institutes and diagnostic laboratories.
Additional Questions Answered
Some of the additional questions answered in this report on gastrointestinal infection testing market are-
- What is the revenue potential of the gastrointestinal infection testing market across North America and Europe?
- Who are the key players and what are their product portfolios in the gastrointestinal infection testing market?
- What are the major challenges impacting the growth of the gastrointestinal infection testing market?
- How is the involvement of key regulatory bodies shaping the growth of the gastrointestinal infection testing market?
The gastrointestinal infection testing market has been studied from a supply-demand side approach. Further, qualitative factors impacting the gastrointestinal infection testing market, such as awareness regarding gastrointestinal infection testing and treatments available, average price of devices or average cost of test, key regulations and others, have also been discussed in the market.
The calculated data has been further validated through primary research, including telephonic interviews, surveys, in-person interactions and viewpoints of experienced analysts. Secondary research resources, such as databases, trade journals and verified paid sources, were used to arrive at observations drawn.
The research study on the gastrointestinal infection testing market also includes top trends and macro as well as microeconomic factors influencing the gastrointestinal infection testing market.